- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06622525
Use of Sodium Bicarbonate As Prophylaxis for Kidney Damage in Patients with Heatstroke
September 30, 2024 updated by: Hospital General de Mexicali
This study protocol aims to prevent the need for renal replacement therapy in patients with rhabdomyolysis secondary to heatstroke.
It is based on previous studies showing that bicarbonate infusion reduces renal failure in similar contexts.
The intervention will be conducted at the General Hospital of Mexicali during the summer, targeting the prevention of renal failure and reducing the necessity for renal replacement therapy.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
The present study protocol explores the possibility of preventing the need for renal replacement therapy in patients who develop rhabdomyolysis secondary to heatstroke.
This is based on previous studies that have used bicarbonate infusion in the context of rhabdomyolysis secondary to compartment syndrome, finding a lower incidence of renal failure.
Due to the aforementioned, we propose to carry out a similar intervention at the General Hospital of Mexicali, where there is a significant incidence of heatstroke during the summer months.
The aim is to determine whether this intervention is useful in preventing the development of renal failure and the requirement for renal replacement therapy.
Study Type
Interventional
Enrollment (Estimated)
1
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joaquin Cordova Erberk, MD
- Phone Number: +52 653 132 0309
- Email: joaquincerberk@gmail.com
Study Contact Backup
- Name: Hiram J Jaramillo Ramirez, MD
- Phone Number: +52 653 132 0309
- Email: grupoinvestigacionmedica@gmail.com
Study Locations
-
-
Baja California
-
Mexicali, Baja California, Mexico, 21000
- Recruiting
- Hospital General de Mexicali
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Admitted to the General Hospital of Mexicali with the diagnosis of heat stroke.
- Meeting the operational definition (exposure to heat, body temperature at admission greater than 40 degrees Celsius).
- CPK level greater than 1000 U/L.
- Having informed consent from the patient or the legally responsible adult.
Exclusion Criteria:
- Exclusion of the heat stroke diagnosis during their evaluation.
- Lack of serum creatinine levels at the time of admission to the protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.
|
This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.
|
|
Active Comparator: Control Group
This group will be manage with the usual care that is given to patients with heat stroke in this hospital.
|
The usual management for heat stroke will be given to this group
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The use of sodium bicarbonate reduces the need for renal replacement therapy
Time Frame: From enrollment until discharge or death.
|
Determine if the use of sodium bicarbonate as a prophylactic measure reduces the need for renal replacement therapy in patients with heat stroke-associated rhabdomyolysis.
|
From enrollment until discharge or death.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Creatinine levels
Time Frame: From enrollment until discharge or death.
|
Describe the creatinine levels of patients diagnosed with heat stroke at the General Hospital of Mexicali.
|
From enrollment until discharge or death.
|
|
Mortality rate
Time Frame: From enrollment until discharge or death.
|
Determine the mortality rate of patients admitted with the diagnosis of heat stroke at the General Hospital of Mexicali.
|
From enrollment until discharge or death.
|
|
Mortality rate of patients diagnosed with heat stroke who were administered bicarbonate compared to those who did not receive bicarbonate.
Time Frame: From enrollment until discharge or death.
|
Determine the mortality rate of patients diagnosed with heat stroke who were administered bicarbonate compared to those who did not receive bicarbonate.
|
From enrollment until discharge or death.
|
|
Potassium levels in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.
Time Frame: From enrollment until discharge or death.
|
Describe the potassium levels in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.
|
From enrollment until discharge or death.
|
|
Difference in the length of hospital stay for patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.
Time Frame: From enrollment until discharge or death.
|
Determine if there is a difference in the length of hospital stay for patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.
|
From enrollment until discharge or death.
|
|
Difference in the requirements for vasopressors in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.
Time Frame: From enrollment until discharge or death.
|
Establish if there is a difference in the requirements for vasopressors in patients
|
From enrollment until discharge or death.
|
|
Use of mechanical ventilation in patients diagnosed with heat stroke
Time Frame: From enrollment until discharge or death.
|
Establish if there is a difference in the use of mechanical ventilation in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.
|
From enrollment until discharge or death.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hiram J Jaramillo Ramirez, MD, Hospital General de Mexicali
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2024
Primary Completion (Estimated)
October 1, 2025
Study Completion (Estimated)
October 1, 2025
Study Registration Dates
First Submitted
June 6, 2024
First Submitted That Met QC Criteria
September 30, 2024
First Posted (Actual)
October 2, 2024
Study Record Updates
Last Update Posted (Actual)
October 2, 2024
Last Update Submitted That Met QC Criteria
September 30, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HGMexicali
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There will be no disclousure of the patients information to thrid party members.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.